These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 8385705)

  • 1. The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog.
    Long HM; Meckiff BJ; Taylor GS
    Front Immunol; 2019; 10():2193. PubMed ID: 31620125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of Epstein-Barr Virus (EBV) Neutralizing and Virus-Specific Antibodies after Primary Infection with EBV.
    Bu W; Hayes GM; Liu H; Gemmell L; Schmeling DO; Radecki P; Aguilar F; Burbelo PD; Woo J; Balfour HH; Cohen JI
    Clin Vaccine Immunol; 2016 Apr; 23(4):363-9. PubMed ID: 26888186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious Mononucleosis.
    Dunmire SK; Hogquist KA; Balfour HH
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):211-40. PubMed ID: 26424648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.
    Long HM; Chagoury OL; Leese AM; Ryan GB; James E; Morton LT; Abbott RJ; Sabbah S; Kwok W; Rickinson AB
    J Exp Med; 2013 May; 210(5):933-49. PubMed ID: 23569328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.
    Long HM; Haigh TA; Gudgeon NH; Leen AM; Tsang CW; Brooks J; Landais E; Houssaint E; Lee SP; Rickinson AB; Taylor GS
    J Virol; 2005 Apr; 79(8):4896-907. PubMed ID: 15795275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.
    Gärtner BC; Hess RD; Bandt D; Kruse A; Rethwilm A; Roemer K; Mueller-Lantzsch N
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):78-82. PubMed ID: 12522043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection.
    Winkelspecht B; Grässer F; Pees HW; Mueller-Lantzsch N
    Arch Virol; 1996; 141(5):857-64. PubMed ID: 8678831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplicity through complexity: immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology.
    Bauer G
    Clin Lab; 2001; 47(5-6):223-30. PubMed ID: 11405600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Epstein-Barr virus nuclear antigen 1,2A and 2B in the baculovirus expression system: serological evaluation of human antibodies to these proteins.
    Hille A; Klein K; Bäumler S; Grässer FA; Mueller-Lantzsch N
    J Med Virol; 1993 Mar; 39(3):233-41. PubMed ID: 8385705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a recombinant enzyme-linked immunosorbent assay for detection of antibodies against Epstein-Barr virus nuclear antigens 2A and 2B.
    Geertsen R; Espander-Jansson A; Dobec M; Price P; Wunderli W; Rymo L
    J Clin Microbiol; 1994 Jan; 32(1):112-20. PubMed ID: 8126164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6.
    Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G
    Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of an Epstein-Barr virus nuclear antigen 2 variant (EBNA 2B) by specific sera.
    Sauter M; Mueller-Lantzsch N
    Virus Res; 1987 Aug; 8(2):141-52. PubMed ID: 2823499
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.